Armon Sharei

2020

In 2020, Armon Sharei earned a total compensation of $2.3M as Chief Executive Officer at SQZ Biotechnologies Co, a 132% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$218,251
Option Awards$1,631,574
Salary$467,313
Other$7,005
Total$2,324,143

Sharei received $1.6M in option awards, accounting for 70% of the total pay in 2020.

Sharei also received $218.3K in non-equity incentive plan, $467.3K in salary and $7K in other compensation.

Rankings

In 2020, Armon Sharei's compensation ranked 4,877th out of 13,090 executives tracked by ExecPay. In other words, Sharei earned more than 62.7% of executives.

ClassificationRankingPercentile
All
4,877
out of 13,090
63rd
Division
Manufacturing
1,983
out of 5,621
65th
Major group
Chemicals And Allied Products
784
out of 2,254
65th
Industry group
Drugs
676
out of 1,954
65th
Industry
Biological Products, Except Diagnostic Substances
159
out of 411
61st
Source: SEC filing on April 26, 2021.

Sharei's colleagues

We found four more compensation records of executives who worked with Armon Sharei at SQZ Biotechnologies Co in 2020.

2020

Micah Zajic

SQZ Biotechnologies Co

Chief Business Officer

2020

Lawrence Knopf

SQZ Biotechnologies Co

General Counsel

2020

Oliver Rosen

SQZ Biotechnologies Co

Chief Medical Officer

2020

Teri Loxam

SQZ Biotechnologies Co

Chief Financial Officer

News

In-depth

You may also like